CliffBio
small molecule

MUCINEX

GUAIFENESIN

Loss of exclusivity—loss of exclusivity
CompanyRECKITT BENCKISER LLC

Drug detail

Brand nameMUCINEX
Active ingredientGUAIFENESIN
Strength1.2GM
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2002
Marketing statusOTC

More from RECKITT BENCKISER LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.